SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000911916-20-000127
Filing Date
2020-06-05
Accepted
2020-06-05 17:37:17
Documents
1
Period of Report
2020-02-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 6538
  Complete submission text file 0000911916-20-000127.txt   8036
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PALIDADE CAPITAL ONE BRIDGE PLAZA NORTH #695 FORT LEE NJ 07024
Business Address
VERU DENNISON T (Reporting) CIK: 0001225341 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-21088 | Film No.: 20947468